{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:48Z","timestamp":1762867128987,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"VA Informatics and Computing Infrastructure","award":["VA HSR RES 13-457"],"award-info":[{"award-number":["VA HSR RES 13-457"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["Interagency Agreement 14001-0000-01001"],"award-info":[{"award-number":["Interagency Agreement 14001-0000-01001"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12911-017-0475-8","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T14:53:27Z","timestamp":1496156007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration"],"prefix":"10.1186","volume":"17","author":[{"given":"Olga","family":"Efimova","sequence":"first","affiliation":[]},{"given":"Brygida","family":"Berse","sequence":"additional","affiliation":[]},{"given":"Daniel W.","family":"Denhalter","sequence":"additional","affiliation":[]},{"given":"Scott L.","family":"DuVall","sequence":"additional","affiliation":[]},{"given":"Kelly K.","family":"Filipski","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Icardi","sequence":"additional","affiliation":[]},{"given":"Michael J.","family":"Kelley","sequence":"additional","affiliation":[]},{"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"475_CR1","unstructured":"American Cancer Society. What are the key statistics about lung cancer? [\n                    http:\/\/www.cancer.org\/cancer\/lungcancer-non-smallcell\/detailedguide\/non-small-cell-lung-cancer-key-statistics\n                    \n                  ]."},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.annepidem.2009.11.012","volume":"20","author":"HA Young","year":"2010","unstructured":"Young HA, Maillard JD, Levine PH, Simmens SJ, Mahan CM, Kang HK. Investigating the risk of cancer in 1990\u20131991 US Gulf War veterans with the use of state cancer registry data. Ann Epidemiol. 2010;20:265\u201372. e1.","journal-title":"Ann Epidemiol"},{"key":"475_CR3","unstructured":"American Cancer Society. Non-small cell lung cancer survival rates by stage. [\n                    http:\/\/www.cancer.org\/cancer\/lungcancer-non-smallcell\/detailedguide\/non-small-cell-lung-cancer-survival-rates\n                    \n                  ]. Accessed 16 Feb 2016."},{"key":"475_CR4","unstructured":"U.S. Food and Drug Administration. FDA News Release. FDA approves Keytruda for advanced non-small cell lung cancer. [\n                    http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm465444.htm\n                    \n                  ]. Accessed 4 Apr 2017."},{"key":"475_CR5","unstructured":"National Cancer Institute. FDA Approval for Erlotinib Hydrochloride. [\n                    http:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/fda-erlotinib-hydrochloride\n                    \n                  ]. Accessed 4 Apr 2017."},{"key":"475_CR6","first-page":"645","volume":"11","author":"DS Ettinger","year":"2013","unstructured":"Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, et al. Non-small cell lung cancer, version 2.2013. JNatlComprCanc Netw. 2013;11:645\u201353. quiz 53.","journal-title":"JNatlComprCanc Netw"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2014.57.3055","volume":"32","author":"NB Leighl","year":"2014","unstructured":"Leighl NB, Rekhtman N, Biermann WA, Huang J, Mino-Kenudson M, Ramalingam SS, et al. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists\/International Association for the Study of Lung Cancer\/Association for Molecular Pathology guideline. J Clin Oncol. 2014;32:3673\u20139.","journal-title":"J Clin Oncol"},{"key":"475_CR8","unstructured":"National Comprehensive Cancer Network. The NCCN Clinical Practice Guidelines in Oncology for Non-Small Cell Lung Cancer version 5.2017. [\n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf\n                    \n                  ]. Accessed 4 Apr 2017."},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-015-0193-6","volume":"8","author":"W Sun","year":"2015","unstructured":"Sun W, Yuan X, Tian Y, Wu H, Xu H, Hu G, et al. Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer. J Hematol Oncol. 2015;8:95.","journal-title":"J Hematol Oncol"},{"key":"475_CR10","first-page":"29","volume":"3","author":"AJ van der Wekken","year":"2015","unstructured":"van der Wekken AJ, Hiltermann TJ, Groen HJ. The value of proteomics in lung cancer. Ann Transl Med. 2015;3:29.","journal-title":"Ann Transl Med"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1185\/03007995.2014.934792","volume":"30","author":"W Sun","year":"2014","unstructured":"Sun W, Hu G, Long G, Wang J, Liu D. Predictive value of a serum-based proteomic test in non-small-cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors: a meta-analysis. Curr Med Res Opin. 2014;30:2033\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 1","key":"475_CR12","first-page":"415","volume":"23","author":"SL DuVall","year":"2014","unstructured":"DuVall SL, Forbush TB, Cornia RC, Ginter T, Adams B, Palmer MN, et al. Reducing the manual burden of medical record review through informatics. Pharmacoepidemiol Drug Saf. 2014;23 Suppl 1:415.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"475_CR13","doi-asserted-by":"crossref","unstructured":"Lynch JA, Berse B, Chun D, Rivera D, Filipski KK, Kulich S, et al. Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. Clin Lung Cancer. 2016.","DOI":"10.1016\/j.cllc.2016.11.018"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-017-0475-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-017-0475-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-017-0475-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:06:11Z","timestamp":1589468771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-017-0475-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s12911-017-0475-8","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2017,5,30]]},"assertion":[{"value":"21 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}